Tips for searching:
• You have to select a product and type at least 2 words to activate the search
• Use only words that are specific to the information you are looking for
• Avoid typing questions or sentences
Please do not use this field to report adverse events or product complaints. Adverse events and product complaints should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow card in the Google play or Apple app store. Adverse events and product complaints should also be reported to Lilly: please call Lilly UK on 01256 315 000.
Zyprexa ® (olanzapine)
This information is intended for UK registered healthcare professionals only as a scientific exchange in response to your search for information. For current prescribing information for all Lilly products, including Summaries of Product Characteristics, Patient Information Leaflets and Instructions for Use, please visit: www.medicines.org.uk (England, Scotland, Wales) or www.emcmedicines.com/en-GB/northernireland/ (Northern Ireland).
Zyprexa® coated tablets (olanzapine): List of excipients
Zyprexa coated tablets contain additional ingredients
ZYPREXA 2.5 mg, 5 mg, 7.5 mg, and 10 mg coated tablets:
Colour mixture white (hypromellose, titanium dioxide [E171], macrogol, polysorbate 80) Carnauba wax
Edible blue ink (shellac, ethanol anhydrous, isopropyl alcohol, butyl alcohol, propylene glycol, ammonium hydroxide, indigo carmine [E132])
ZYPREXA 15 mg coated tablets:
Colour mixture light blue (titanium dioxide [E171], lactose monohydrate, hypromellose, triacetin, indigo carmine [E132])
ZYPREXA 20 mg coated tablets:
Colour mixture pink (titanium dioxide [E171], macrogol, lactose monohydrate, hypromellose, synthetic red iron oxide)
Zyprexa [Summary of Product Characteristics]. Utrecht, The Netherlands: Eli Lilly Nederland B.V.
Date of Last Review: 14 December 2021